Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience

A strategy of routine anticoagulation for 3-months after TAVR is well tolerated and associated with similar or lower bleeding risk compared to antiplatelet therapy.